PolyPeptide Group AG (LON: 0AAJ)

London flag London · Delayed Price · Currency is GBP · Price in CHF
26.35
+0.35 (1.35%)
Jan 23, 2025, 8:08 AM BST
85.69%
Market Cap 765.80M
Revenue (ttm) 274.34M
Net Income (ttm) -24.21M
Shares Out n/a
EPS (ttm) -0.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 214
Average Volume 506
Open 26.20
Previous Close 26.00
Day's Range 26.20 - 26.35
52-Week Range 14.19 - 26.35
Beta 1.12
RSI 43.72
Earnings Date Mar 11, 2025

About PolyPeptide Group AG

PolyPeptide Group AG operate as a contract development and manufacturing company in Europe, the United States, and India. It develops and manufactures synthetic peptides and oligonucleotides used as active pharmaceutical ingredients or intermediates in therapeutic products for pharmaceutical and biotech companies. The company offers portfolio of peptide-based therapies for metabolic disorders, including the GLP-1 receptor agonist drugs for the treatment of type 2 diabetes, obesity, and other co-morbidities, as well as oncology, hormonal disorde... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1952
Employees 1,273
Stock Exchange London Stock Exchange
Ticker Symbol 0AAJ
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.